Product Characteristics

It is stable under normal conditions of storage and possesses excellent flow characteristics that make possible the use of a fine-gauge needle for injection.

Spectinomycin has a low degree of toxicity.

Subcutaneous injections of up to 50 mg per poult have caused no detectable ill effects. Doses of 90 mg per poult have produced transient ataxis and coma from which poults recovered in approximately four hours. Under postmortem examination no local tissue reaction has been observed following the injection of Spectam.

Spectam Injectable Indications For Use

As an aid in the reduction of mortality in turkeys due to fowl cholera caused by strains of Pasteurellamultocida sensitive to spectinomycin.

Administration

Spectam is intended only for subcutaneous injection. The injection should be made under the loose skin on top of the neck, halfway between the head and the base of the neck.

Thoroughly clean and sterilize syringes and needles before using (needles and syringes may be sterilized by boiling in water for 15 minutes).

Use all precautions to prevent contamination of contents of bottle.

Injection site should be disinfected with a suitable disinfectant such as 70% isopropyl alcohol just prior to injecting Spectam.

All birds in the flock should be treated as soon as symptoms of the disease are observed.

Dosage

Studies have shown a dosage of 11 to 22 mg per kg of body weight is effective. The following table illustrates the amount of product required:

Weight

Dose

2.3 kg

0.25 to 0.5 mL

4.5 kg

0.50 to 1.0 mL

6.8 kg

0.75 to 1.5 mL

Spectam Injectable Caution

Do not administer to birds under 0.5 kg body weight.

A repeated treatment must not be given within 5 days of the initial treatment.

Warning

Treated birds must not be slaughtered for use as food for at least 5 days after the latest treatment with this drug. This product must not be used in laying birds.

Rarely, some individuals who handle spectinomycin develop serious reactions involving skin, nails and eyes. Individuals who have experienced rash or other evidence of allergic reaction should avoid further contact with spectinomycin.

Nac No.

Every effort has been made to ensure the accuracy of the Spectam Injectable information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.